Endodermal sinus tumor

Revision as of 14:27, 9 March 2010 by Apalmer (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Editor-in-Chief: Somal Khan, M.D.

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Endodermal sinus tumor
ICD-O: 9071/3
DiseasesDB 4248
MeSH D018240

Template:Search infobox

Overview

Endodermal sinus tumor (EST), also known as yolk sac tumor (YST), is a member of the germ cell tumor group of cancers. Endodermal sinus tumor frequently develops within other kinds of germ cell tumor, particularly within teratoma. While pure teratoma is usually benign, endodermal sinus tumor is malignant.

Diagnosis

The histology of EST is variable, but usually includes malignant endodermal cells. These cells express alpha-fetoprotein (AFP), which can be detected in tumor tissue or serum. When there is incongruence between biopsy and AFP test results for EST, the result indicating presence of EST should guide treatment.[1] This is because EST often occurs as small "malignant foci" within a larger tumor, usually teratoma; biopsy of the tumor may reveal only teratoma, whereas elevated AFP in serum or cerebrospinal fluid reveals that EST is also present. GATA-4, a transcription factor, also may be useful in the diagnosis of EST.[2]

Treatment

Most treatments involve some combination of surgery and chemotherapy.

Before modern chemotherapy, this type of neoplasm was highly lethal, but the prognosis has significantly improved since.

References

  1. Luther N, Edgar MA, Dunkel IJ, Souweidane MM (2006). "Correlation of endoscopic biopsy with tumor marker status in primary intracranial germ cell tumors". J. Neurooncol. 79 (1): 45–50. doi:10.1007/s11060-005-9110-0. PMID 16598424.
  2. Siltanen S, Anttonen M, Heikkilä P, Narita N, Laitinen M, Ritvos O, Wilson DB, Heikinheimo M (1999). "Transcription factor GATA-4 is expressed in pediatric yolk sac tumors". Am. J. Pathol. 155 (6): 1823–9. PMID 10595911. (free full text on PubMed Central)

External links


Template:SIB Template:Tumors


Template:WikiDoc Sources